ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,316Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 1171

$1.71M Total Retail Price of All Prescriptions

Rank: 7 out of 1171

905 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 905 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 905 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 21,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
HYDROCODONE-ACETAMINOPHEN 1,409 772 S3 1 8
LEVOTHYROXINE SODIUM 1,287 1,035 2 4
LISINOPRIL 977 671 3 3
OMEPRAZOLE 889 657 4 5
AMLODIPINE BESYLATE 839 702 5 2
FUROSEMIDE 719 544 6 6
PRAVASTATIN SODIUM 675 575 7 13
HYDRALAZINE HCL 625 495 8 60
POTASSIUM CHLORIDE 530 384 9 19
CITALOPRAM HBR 519 353 10 22
GABAPENTIN 493 350 11 16
ATENOLOL 486 340 12 15
METFORMIN HCL 468 302 13 7
ISOSORBIDE MONONITRATE ER 458 401 14 44
ZOLPIDEM TARTRATE 437 288 15 21
SIMVASTATIN 422 347 16 1
METOPROLOL TARTRATE 401 289 17 11
METFORMIN HCL ER 363 261 18 52
OXYCODONE HCL 327 91 S2 19 79
PANTOPRAZOLE SODIUM 326 221 20 29
DIOVAN 304 248 21 32
WARFARIN SODIUM 302 234 22 12
ATORVASTATIN CALCIUM 289 262 23 10
HYDROCHLOROTHIAZIDE 271 170 24 9
LOSARTAN POTASSIUM 253 195 25 14
CARVEDILOL 251 218 26 20
BYSTOLIC 243 218 27 96
ALLOPURINOL 237 201 28 31
NEXIUM 233 170 29 25
PREDNISONE 219 178 30 39
CLOPIDOGREL 218 186 31 35
METOPROLOL SUCCINATE 214 193 32 17
CLONIDINE HCL 214 143 32 45
CEFUROXIME 206 172 34 169
SERTRALINE HCL 198 142 35 23
AMOXICILLIN 195 137 36 111
RANITIDINE HCL 182 132 37 38
KLOR-CON M20 180 123 38 41
GLIMEPIRIDE 178 113 39 34
TRAZODONE HCL 167 74 40 37
CRESTOR 166 108 41 27
SPIRONOLACTONE 163 119 42 53
TRAMADOL HCL 162 119 43 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 155 105 44 26
AZITHROMYCIN 155 110 44 43
RAMIPRIL 149 123 46 85
DICLOFENAC SODIUM 147 94 47 103
ZETIA 143 140 48 63
PLAVIX 142 116 49 55
VERAPAMIL ER 138 104 50 91
LANTUS 135 100 51 46
NAMENDA 132 131 52 42
DOXYCYCLINE HYCLATE 131 98 53 137
PROMETHAZINE HCL 128 32 R 54 87
DONEPEZIL HCL 127 126 55 24
CYMBALTA 120 41 56 64
FENOFIBRATE 119 92 57 81
NATEGLINIDE 118 104 58 286
QUETIAPINE FUMARATE 117 83 59 54
ALPRAZOLAM 116 90 60 184
ESCITALOPRAM OXALATE 112 78 61 69
PHENYTOIN SODIUM EXTENDED 111 48 62 137
LEVETIRACETAM 108 75 63 84
FLUOXETINE HCL 107 48 64 76
SYNTHROID 106 68 65 48
AMITRIPTYLINE HCL 103 78 R 66 74
METHADONE HCL 102 0 S2 67 144
TAMSULOSIN HCL 99 70 68 28
OXYCODONE-ACETAMINOPHEN 98 44 S2 69 59
PAROXETINE HCL 96 53 70 62
AMLODIPINE BESYLATE-BENAZEPRIL 94 67 71 70
POLYETHYLENE GLYCOL 3350 89 73 72 72
MIRTAZAPINE 89 49 72 50
DIOVAN HCT 89 74 72 65
PROPRANOLOL HCL 88 44 75 134
PROAIR HFA 88 49 75 49
BUPROPION HCL 86 30 77 342
FLUTICASONE PROPIONATE 83 61 78 30
GEMFIBROZIL 83 28 78 117
BUSPIRONE HCL 83 47 78 129
SOTALOL 83 64 78 294
DILTIAZEM 24HR CD 82 58 82 101
CIPROFLOXACIN HCL 81 59 83 61
JANUVIA 80 68 84 66
BENICAR 79 79 85 181
MECLIZINE HCL 78 74 86 115
TRILIPIX 75 46 87 198
LACTULOSE 74 56 88 108
METRONIDAZOLE 74 61 88 294
LANSOPRAZOLE 73 52 90 150
PEN NEEDLE 72 51 91 122
LOSARTAN-HYDROCHLOROTHIAZIDE 71 65 92 40
LANTUS SOLOSTAR 71 40 92 90
INSULIN SYRINGE 70 32 94 71
NIFEDIPINE ER 70 70 94 114
OXYCONTIN 69 12 S2 96 186
CYCLOBENZAPRINE HCL 67 25 R 97 67
METOLAZONE 66 41 98 206
PRADAXA 66 50 98 248
ADVAIR DISKUS 65 48 100 51
OXYCODONE HCL-ACETAMINOPHEN 64 0 S2 101 99
IMIPRAMINE HCL 64 41 R 101 372
DIPHENOXYLATE-ATROPINE 64 36 101 361
NITROFURANTOIN 63 33 104 287
NITROSTAT 63 51 104 180
SPIRIVA 62 38 106 57
IPRATROPIUM-ALBUTEROL 62 55 106 130
LYRICA 61 51 108 127
GLIPIZIDE ER 61 61 108 86
AGGRENOX 60 52 110 148
LEVEMIR FLEXPEN 60 41 110 145
COUMADIN 59 59 112 253
TRICOR 59 33 112 140
HYDROXYZINE HCL 59 35 R 112 168
EXFORGE 59 39 112 208
LIPITOR 57 55 116 92
FLUCONAZOLE 57 29 116 195
NOVOLOG MIX 70-30 57 34 116 207
DEXILANT 57 23 116 239
NYSTATIN 56 51 120 128
EXELON 55 55 121 164
MUPIROCIN 55 40 121 231
DILTIAZEM 24HR ER 53 51 123 112
FENTANYL 53 0 S2 123 89
COLCRYS 53 52 123 159
METHOCARBAMOL 52 28 R 126 274
NASONEX 51 32 127 218
DIVALPROEX SODIUM ER 50 30 128 220
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.